203 related articles for article (PubMed ID: 26382939)
1. Neuroprotective effect of selective DPP-4 inhibitor in experimental vascular dementia.
Jain S; Sharma B
Physiol Behav; 2015 Dec; 152(Pt A):182-93. PubMed ID: 26382939
[TBL] [Abstract][Full Text] [Related]
2. Effect of ruthenium red, a ryanodine receptor antagonist in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats.
Jain S; Sharma B
Physiol Behav; 2016 Oct; 164(Pt A):140-50. PubMed ID: 27262216
[TBL] [Abstract][Full Text] [Related]
3. Calcium Channel Blockade and Peroxisome Proliferator Activated Receptor γ Agonism Diminish Cognitive Loss and Preserve Endothelial Function During Diabetes Mellitus.
Jain S; Sharma BM; Sharma B
Curr Neurovasc Res; 2016; 13(1):33-44. PubMed ID: 26648342
[TBL] [Abstract][Full Text] [Related]
4. Arsenic toxicity induced endothelial dysfunction and dementia: pharmacological interdiction by histone deacetylase and inducible nitric oxide synthase inhibitors.
Sharma B; Sharma PM
Toxicol Appl Pharmacol; 2013 Nov; 273(1):180-8. PubMed ID: 23921152
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Cilostazol a selective phosphodiesterase-3 inhibitor in rat model of Streptozotocin diabetes induced vascular dementia.
Kumar A; Kumar A; Jaggi AS; Singh N
Pharmacol Biochem Behav; 2015 Aug; 135():20-30. PubMed ID: 25987325
[TBL] [Abstract][Full Text] [Related]
6. SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats.
Sa-Nguanmoo P; Tanajak P; Kerdphoo S; Jaiwongkam T; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
Toxicol Appl Pharmacol; 2017 Oct; 333():43-50. PubMed ID: 28807765
[TBL] [Abstract][Full Text] [Related]
7. Favorable effects of vildagliptin on metabolic and cognitive dysfunctions in streptozotocin-induced diabetic rats.
El Batsh MM; El Batch MM; Shafik NM; Younos IH
Eur J Pharmacol; 2015 Dec; 769():297-305. PubMed ID: 26607467
[TBL] [Abstract][Full Text] [Related]
8. Salutary effect of NFκB inhibitor and folacin in hyperhomocysteinemia-hyperlipidemia induced vascular dementia.
Sharma B; Singh N
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):207-15. PubMed ID: 22510463
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl peptidase 4 inhibitor improves brain insulin sensitivity, but fails to prevent cognitive impairment in orchiectomy obese rats.
Pintana H; Pongkan W; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
J Endocrinol; 2015 Aug; 226(2):M1-M11. PubMed ID: 26016746
[TBL] [Abstract][Full Text] [Related]
10. DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption.
Pipatpiboon N; Pintana H; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
Eur J Neurosci; 2013 Mar; 37(5):839-49. PubMed ID: 23240760
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways.
Abdelsalam RM; Safar MM
J Neurochem; 2015 Jun; 133(5):700-7. PubMed ID: 25752913
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction.
Inthachai T; Lekawanvijit S; Kumfu S; Apaijai N; Pongkan W; Chattipakorn SC; Chattipakorn N
Exp Physiol; 2015 Jun; 100(6):667-79. PubMed ID: 25823534
[TBL] [Abstract][Full Text] [Related]
13. Gastrodin improves cognitive dysfunction and decreases oxidative stress in vascular dementia rats induced by chronic ischemia.
Li Y; Zhang Z
Int J Clin Exp Pathol; 2015; 8(11):14099-109. PubMed ID: 26823723
[TBL] [Abstract][Full Text] [Related]
14. Vildagliptin selectively ameliorates GLP-1, GLUT4, SREBP-1c mRNA levels and stimulates β-cell proliferation resulting in improved glucose homeostasis in rats with streptozotocin-induced diabetes.
Akarte AS; Srinivasan BP; Gandhi S
J Diabetes Complications; 2012; 26(4):266-74. PubMed ID: 22626875
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of vildagliptin against cerebral ischemia in rats.
El-Marasy SA; Abdel-Rahman RF; Abd-Elsalam RM
Naunyn Schmiedebergs Arch Pharmacol; 2018 Oct; 391(10):1133-1145. PubMed ID: 30022232
[TBL] [Abstract][Full Text] [Related]
16. DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats.
Pintana H; Apaijai N; Chattipakorn N; Chattipakorn SC
J Endocrinol; 2013 Jul; 218(1):1-11. PubMed ID: 23591914
[TBL] [Abstract][Full Text] [Related]
17. Relationships between the islets blood flow, nitric oxide, insulin, and cytosolic calcium in rat pancreatic islets: effects of DPP-IV inhibitor vildagliptin.
Akarte AS; Srinivasan BP; Gandhi S
Eur J Pharm Sci; 2012 Apr; 45(5):546-51. PubMed ID: 22155545
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of inducible nitric oxide synthase (iNOS) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, convalesce behavior and biochemistry of hypertension induced vascular dementia in rats.
Sharma B; Singh N
Pharmacol Biochem Behav; 2013 Feb; 103(4):821-30. PubMed ID: 23201648
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats.
Sharma B; Singh N
Pharmacol Biochem Behav; 2011 Dec; 100(2):320-9. PubMed ID: 21893084
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of bosentan, a dual ETA and ETB endothelin receptor antagonist, in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats.
Singh G; Sharma B; Jaggi AS; Singh N
Pharmacol Biochem Behav; 2014 Sep; 124():27-35. PubMed ID: 24836182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
